{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:15:44Z","timestamp":1774923344727,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.psc.2010.04.008","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T08:10:52Z","timestamp":1278317452000},"page":"687-699","source":"Crossref","is-referenced-by-count":36,"title":["Augmentation of Cognitive Behavioral Therapy with Pharmacotherapy"],"prefix":"10.1016","volume":"33","author":[{"given":"K.A.","family":"Ganasen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Ipser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2010.04.008_bib1","series-title":"Competency in combining pharmacotherapy and psychotherapy: integrated and split treatment","author":"Riba","year":"2005"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0095-4543(05)70318-3","article-title":"Behavioral medicine, complementary medicine and integrated care. Economic implications","volume":"24","author":"Friedman","year":"1997","journal-title":"Prim Care"},{"key":"10.1016\/j.psc.2010.04.008_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2010.04.008_bib4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2010.04.008_bib5","first-page":"329","article-title":"Integrating therapies for anxiety disorders","volume":"35","author":"Hollifield","year":"2006","journal-title":"Psychiatr Ann"},{"issue":"12","key":"10.1016\/j.psc.2010.04.008_bib6","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A\u00a0meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"10\u00a0Suppl\u00a012","key":"10.1016\/j.psc.2010.04.008_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S1092852900025827","article-title":"Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders","volume":"11","author":"Black","year":"2006","journal-title":"CNS Spectr"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1891\/088983907780493304","article-title":"Combining medication treatment and cognitive-behavior therapy for bipolar disorder","volume":"21","author":"Basco","year":"2007","journal-title":"J\u00a0Cogn Psychother"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1891\/088983907780493359","article-title":"Cognitive-behavior therapy with eating disorders: the role of medications in treatment","volume":"21","author":"Bowers","year":"2007","journal-title":"J\u00a0Cogn Psychother"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1891\/088983907780493278","article-title":"Combining cognitive therapy and pharmacotherapy for schizophrenia","volume":"21","author":"Kingdon","year":"2007","journal-title":"J\u00a0Cogn Psychother"},{"issue":"19","key":"10.1016\/j.psc.2010.04.008_bib12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2009.682","article-title":"Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial","volume":"301","author":"Morin","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004850-199001000-00002","article-title":"A\u00a0controlled study of fluvoxamine and exposure in obsessive-compulsive disorder","volume":"5","author":"Cottraux","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/S0007125000297924","article-title":"Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study","volume":"35","author":"Hohagen","year":"1998","journal-title":"Br J Psychiatry Suppl"},{"issue":"8","key":"10.1016\/j.psc.2010.04.008_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00005053-199808000-00007","article-title":"Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder","volume":"186","author":"van Balkom","year":"1998","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.psc.2010.04.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.136.1.1","article-title":"Clomipramine and exposure for obsessive-compulsive rituals: i","volume":"136","author":"Marks","year":"1980","journal-title":"Br J Psychiatry"},{"issue":"19","key":"10.1016\/j.psc.2010.04.008_bib18","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.psc.2010.04.008_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1192\/bjp.167.5.635","article-title":"A\u00a0controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia","volume":"167","author":"Cottraux","year":"1995","journal-title":"Br J Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2010.04.008_bib20","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0005-7967(03)00032-9","article-title":"Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone","volume":"41","author":"Otto","year":"2003","journal-title":"Behav Res Ther"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.psychotherapy.1993.47.3.404","article-title":"The interaction between pharmacotherapy and psychotherapy in the treatment of posttraumatic stress disorder","volume":"47","author":"Southwick","year":"1993","journal-title":"Am J Psychother"},{"key":"10.1016\/j.psc.2010.04.008_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.179.1.23","article-title":"Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia","volume":"179","author":"Blomhoff","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2010.04.008_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archpsyc.61.10.1005","article-title":"Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia","volume":"61","author":"Davidson","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archgenpsychiatry.2010.11","article-title":"A\u00a0placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder","volume":"67","author":"Blanco","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"26","key":"10.1016\/j.psc.2010.04.008_bib25","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.psc.2010.04.008_bib26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder","volume":"150","author":"Otto","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"20","key":"10.1016\/j.psc.2010.04.008_bib27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","article-title":"A\u00a0comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression","volume":"342","author":"Keller","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.psc.2010.04.008_bib28","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1073\/pnas.2336126100","article-title":"Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma","volume":"100","author":"Nemeroff","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.psc.2010.04.008_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.chi.0000233157.21925.71","article-title":"A\u00a0comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression","volume":"45","author":"Melvin","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1016\/j.psc.2010.04.008_bib30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.chi.0000237709.35637.c0","article-title":"The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks","volume":"45","author":"March","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2010.04.008_bib31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4088\/JCP.v66n1108","article-title":"Sequential treatment of mood and anxiety disorders","volume":"66","author":"Fava","year":"2005","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib32","first-page":"281","article-title":"Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression","volume":"27","author":"Segal","year":"2002","journal-title":"J\u00a0Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000344917.43780.77","article-title":"Medication adherence: a review of the literature and implications for clinical practice","volume":"15","author":"Julius","year":"2009","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/npp.2009.83","article-title":"The neurocircuitry of fear, stress, and anxiety disorders","volume":"35","author":"Shin","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biopsych.2006.06.022","article-title":"The promise of extinction research for the prevention and treatment of anxiety disorders","volume":"60","author":"Anderson","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2010.04.008_bib36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0006-3223(02)01665-7","article-title":"Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology","volume":"52","author":"Grillon","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2010.04.008_bib37","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1176\/appi.ajp.159.12.1979","article-title":"Depression, II: localization of pathophysiology","volume":"159","author":"Mayberg","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2010.04.008_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cpr.2007.05.002","article-title":"Neuroimaging studies of psychological interventions for mood and anxiety disorders: empirical and methodological review","volume":"28","author":"Frewen","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(98)00041-9","article-title":"FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder","volume":"84","author":"Brody","year":"1998","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.psc.2010.04.008_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archpsyc.59.5.425","article-title":"Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy","volume":"59","author":"Furmark","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2010.04.008_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.03.029","article-title":"Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo","volume":"58","author":"Furmark","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S1092852900020721","article-title":"Specific phobia. A disorder of fear conditioning and extinction","volume":"11","author":"Stein","year":"2006","journal-title":"CNS Spectr"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1176\/appi.ajp.160.3.522","article-title":"Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression","volume":"160","author":"Saxena","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.psc.2010.04.008_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-4328(93)90102-V","article-title":"Fear-potentiated startle: a neural and pharmacological analysis","volume":"58","author":"Davis","year":"1993","journal-title":"Behav Brain Res"},{"issue":"10","key":"10.1016\/j.psc.2010.04.008_bib46","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0006-3223(02)01507-X","article-title":"The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy","volume":"52","author":"Davis","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"20","key":"10.1016\/j.psc.2010.04.008_bib47","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1523\/JNEUROSCI.18-20-08444.1998","article-title":"Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats","volume":"18","author":"Lee","year":"1998","journal-title":"J\u00a0Neurosci"},{"issue":"39","key":"10.1016\/j.psc.2010.04.008_bib48","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1523\/JNEUROSCI.2466-06.2006","article-title":"Reconsolidation and extinction of conditioned fear: inhibition and potentiation","volume":"26","author":"Lee","year":"2006","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.psc.2010.04.008_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hipo.10043","article-title":"The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear","volume":"13","author":"Szapiro","year":"2003","journal-title":"Hippocampus"},{"issue":"6","key":"10.1016\/j.psc.2010.04.008_bib50","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0896-6273(00)80662-5","article-title":"Postsynaptically silent synapses in single neuron cultures","volume":"21","author":"Gomperts","year":"1998","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.psc.2010.04.008_bib51","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.psc.2010.04.008_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"117","author":"Ledgerwood","year":"2003","journal-title":"Behav Neurosci"},{"issue":"8","key":"10.1016\/j.psc.2010.04.008_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2005.01.023","article-title":"D-Cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction","volume":"57","author":"Ledgerwood","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder","volume":"165","author":"Wilhelm","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib55","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"11","key":"10.1016\/j.psc.2010.04.008_bib56","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J\u00a0Pers Assess"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YIC.0b013e32819f8480","article-title":"D-Cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder","volume":"22","author":"Storch","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.psc.2010.04.008_bib59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2010.04.008_bib60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.biopsych.2009.07.036","article-title":"Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder","volume":"67","author":"Otto","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib61","series-title":"Structured clinical interview for DSM-IV axis I disorders-patient edition (SCID I\/P, version 2.0)","author":"First","year":"1995"},{"key":"10.1016\/j.psc.2010.04.008_bib62","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter collaborative panic disorder severity scale","volume":"154","author":"Shear","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/02698811030173009","article-title":"Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder","volume":"17","author":"Pollack","year":"2003","journal-title":"J\u00a0Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib64","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib65","series-title":"Anxiety disorders interview schedule for DSM-IV: lifetime version (ADIS-IV-L)","author":"DiNardo","year":"1994"},{"key":"10.1016\/j.psc.2010.04.008_bib66","series-title":"Structured clinical interview for DSM-IV (Axis I Disorders)","author":"First","year":"1997"},{"issue":"5","key":"10.1016\/j.psc.2010.04.008_bib67","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0005-7967(89)90093-4","article-title":"The Social Phobia and Anxiety Inventory: concurrent validity with a clinic sample","volume":"27","author":"Beidel","year":"1989","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.psc.2010.04.008_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.psc.2010.04.008_bib69","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A\u00a0randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib70","series-title":"Anxiety disorders interview schedule adult version (ADIS-IV)","author":"Brown","year":"1994"},{"key":"10.1016\/j.psc.2010.04.008_bib71","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0146167283093007","article-title":"A\u00a0brief version of the fear of negative evaluation scale","volume":"9","author":"Leary","year":"1983","journal-title":"Pers Soc Psychol Bull"},{"key":"10.1016\/j.psc.2010.04.008_bib72","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1192\/bjp.bp.106.028167","article-title":"Treatment of social phobia through pure self help and therapist-augmented self help","volume":"191","author":"Rapee","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib73","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1037\/0021-843X.101.4.728","article-title":"Discrepancy between self- and observer ratings of performance in social phobics","volume":"101","author":"Rapee","year":"1992","journal-title":"J\u00a0Abnorm Psychol"},{"key":"10.1016\/j.psc.2010.04.008_bib74","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1016\/j.psc.2010.04.008_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0005-7894(77)80116-0","article-title":"Comparison of self-report and overt-behavioral procedures for assessing acrophobia","volume":"8","author":"Cohen","year":"1977","journal-title":"Behav Ther"},{"key":"10.1016\/j.psc.2010.04.008_bib76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/ajp.152.4.626","article-title":"Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia","volume":"152","author":"Rothbaum","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2010.04.008_bib77","series-title":"Manual for the state-trait anxiety inventory (self-evaluation questionnaire)","author":"Spielberger","year":"1970"},{"issue":"2","key":"10.1016\/j.psc.2010.04.008_bib78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A\u00a0meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2010.04.008_bib79","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/alcalc\/agn067","article-title":"D-Cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats","volume":"43","author":"Vengeliene","year":"2008","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"10.1016\/j.psc.2010.04.008_bib80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.2009.139","article-title":"D-Cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning","volume":"35","author":"Nic Dhonnchadha","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.psc.2010.04.008_bib81","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.09r05021","article-title":"Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis","volume":"70","author":"Cuijpers","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2010.04.008_bib82","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1037\/0033-2909.131.5.785","article-title":"Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy","volume":"131","author":"Mitte","year":"2005","journal-title":"Psychol Bull"},{"key":"10.1016\/j.psc.2010.04.008_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004364.pub2","article-title":"Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia","volume":"1","author":"Furukawa","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.psc.2010.04.008_bib84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1034\/j.1600-0447.2002.1r084.x","article-title":"Treatment non-adherence in affective disorders","volume":"105","author":"Lingam","year":"2002","journal-title":"Acta Psychiatr Scand"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2010.04.008_bib85","first-page":"24","article-title":"Psychotherapy, medication combinations, and compliance","volume":"56","author":"Paykel","year":"1995","journal-title":"J\u00a0Clin Psychiatry"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X1000050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X1000050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:54:01Z","timestamp":1559242441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X1000050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0193953X1000050X"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2010.04.008","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}